KEAP1 and Parkinson disease: To investigate NRF‐2 signaling in PD‐associated cardiomyocytes and skeletal muscle cells, we assessed the protein levels of NRF‐2, Keap‐1, GAA, and actin (Fig. 5D) using Western blot analysis.